Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma

IMPORTANCE: Long-term oncologic outcomes of robotic surgery remain a hotly debated topic in surgical oncology, but sparse data have been published thus far. OBJECTIVE: To analyze short- and long-term outcomes of robotic liver resection (RLR) for hepatocellular carcinoma (HCC) from Western high-volum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of surgery (Chicago. 1960) 2023-01, Vol.158 (1), p.46-54
Hauptverfasser: Di Benedetto, Fabrizio, Magistri, Paolo, Di Sandro, Stefano, Sposito, Carlo, Oberkofler, Christian, Brandon, Ellie, Samstein, Benjamin, Guidetti, Cristiano, Papageorgiou, Alexandros, Frassoni, Samuele, Bagnardi, Vincenzo, Clavien, Pierre-Alain, Citterio, Davide, Kato, Tomoaki, Petrowsky, Henrik, Halazun, Karim J, Mazzaferro, Vincenzo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:IMPORTANCE: Long-term oncologic outcomes of robotic surgery remain a hotly debated topic in surgical oncology, but sparse data have been published thus far. OBJECTIVE: To analyze short- and long-term outcomes of robotic liver resection (RLR) for hepatocellular carcinoma (HCC) from Western high-volume centers to assess the safety, reproducibility, and oncologic efficacy of this technique. DESIGN, SETTING, AND PARTICIPANTS: This cohort study evaluated the outcomes of patients receiving RLR vs open liver resection (OLR) for HCC between 2010 and 2020 in 5 high-volume centers. After 1:1 propensity score matching, a group of patients who underwent RLR was compared with a validation cohort of OLR patients from a high-volume center that did not perform RLR. MAIN OUTCOMES AND MEASURES: A retrospective analysis was performed of prospectively maintained databases at 2 European and 2 US institutions of patients who underwent RLR for HCC between January 1, 2010, and September 30, 2020. The main outcomes were safety and feasibility of RLR for HCC and its oncologic outcomes compared with a European OLR validation cohort. A 2-sided P 
ISSN:2168-6254
2168-6262
2168-6262
DOI:10.1001/jamasurg.2022.5697